Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children's Research Hospital Approach
Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children. In recent Total Therapy studies conducted at St. Jude Children's Research Hospital, children with ALL had a 5-year overall survival of around 94%. This is the result of a combination of risk stratification based o...
Saved in:
Main Authors: | Hiroto Inaba (Author), Elizabeth M. Azzato (Author), Charles G. Mullighan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEXT-GENERATION SEQUENCING IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
by: Klementina Črepinšek, et al.
Published: (2021) -
Energy cost of walking in obese survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort
by: Matthew D. Wogksch, et al.
Published: (2022) -
Leishmania donovani visceral leishmaniasis diagnosed by metagenomics next-generation sequencing in an infant with acute lymphoblastic leukemia: a case report
by: Li Chang, et al.
Published: (2023) -
Jude the Obscure
by: Hardy, Thomas, 1840-1928 -
Editorial: Pediatric acute lymphoblastic leukemia: what's next?
by: J. V. Gil, et al.
Published: (2024)